Eduardo Agüera

3.2k total citations
62 papers, 1.4k citations indexed

About

Eduardo Agüera is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Eduardo Agüera has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pathology and Forensic Medicine, 15 papers in Molecular Biology and 13 papers in Neurology. Recurrent topics in Eduardo Agüera's work include Multiple Sclerosis Research Studies (26 papers), Genetic Neurodegenerative Diseases (7 papers) and Transcranial Magnetic Stimulation Studies (5 papers). Eduardo Agüera is often cited by papers focused on Multiple Sclerosis Research Studies (26 papers), Genetic Neurodegenerative Diseases (7 papers) and Transcranial Magnetic Stimulation Studies (5 papers). Eduardo Agüera collaborates with scholars based in Spain, Mexico and United States. Eduardo Agüera's co-authors include Isaac Túnez, Fernando Sánchez‐López, Montserrat Feijóo, Begoña M. Escribano, Evelio Luque, Adam J. Bograd, Prasad S. Adusumilli, Inmaculada Tasset, Félix Gascón and Camelia S. Sima and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Scientific Reports.

In The Last Decade

Eduardo Agüera

57 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo Agüera Spain 20 370 311 291 197 159 62 1.4k
Dake Huang China 25 667 1.8× 80 0.3× 85 0.3× 162 0.8× 108 0.7× 70 1.6k
Gang Zhu China 24 456 1.2× 116 0.4× 107 0.4× 295 1.5× 292 1.8× 82 1.6k
Xun Zhou China 22 461 1.2× 98 0.3× 66 0.2× 84 0.4× 196 1.2× 79 1.3k
Fang Kuang China 25 683 1.8× 228 0.7× 64 0.2× 379 1.9× 351 2.2× 76 1.8k
Jin Young Chung South Korea 22 410 1.1× 73 0.2× 99 0.3× 170 0.9× 258 1.6× 102 1.4k
Ágnes Zvara Hungary 26 1.1k 3.1× 228 0.7× 51 0.2× 90 0.5× 183 1.2× 68 2.4k
T. Michael De Silva Australia 24 549 1.5× 128 0.4× 197 0.7× 632 3.2× 106 0.7× 36 2.0k
Giacomo Pozzoli Italy 22 575 1.6× 75 0.2× 123 0.4× 232 1.2× 179 1.1× 57 1.9k
Dayun Feng China 26 772 2.1× 83 0.3× 103 0.4× 302 1.5× 264 1.7× 77 1.8k

Countries citing papers authored by Eduardo Agüera

Since Specialization
Citations

This map shows the geographic impact of Eduardo Agüera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Agüera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Agüera more than expected).

Fields of papers citing papers by Eduardo Agüera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Agüera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Agüera. The network helps show where Eduardo Agüera may publish in the future.

Co-authorship network of co-authors of Eduardo Agüera

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Agüera. A scholar is included among the top collaborators of Eduardo Agüera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Agüera. Eduardo Agüera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caballero‐Villarraso, Javier, et al.. (2025). Molecular Mechanisms of the Microbiota–Gut–Brain Axis in the Onset and Progression of Stroke. International Journal of Molecular Sciences. 26(20). 10071–10071. 2 indexed citations
2.
Hassouneh, Fakhri, et al.. (2025). Tandem CAR-T cell therapy: recent advances and current challenges. Frontiers in Immunology. 16. 1546172–1546172. 15 indexed citations
3.
Caballero‐Villarraso, Javier, et al.. (2024). Impact of Cognitive Impairment on Quality of Life in Multiple Sclerosis Patients—A Comprehensive Review. Journal of Clinical Medicine. 13(11). 3321–3321. 12 indexed citations
4.
Escribano, Begoña M., Alejandro Galvao-Carmona, Noelia Villarrubia, et al.. (2024). MIND Diet Impact on Multiple Sclerosis Patients: Biochemical Changes after Nutritional Intervention. International Journal of Molecular Sciences. 25(18). 10009–10009. 5 indexed citations
5.
6.
Escribano, Begoña M., et al.. (2023). Effect of the Combination of Different Therapies on Oxidative Stress in the Experimental Model of Multiple Sclerosis. Neuroscience. 529. 116–128. 4 indexed citations
7.
Escribano, Begoña M., Javier Caballero‐Villarraso, Abel Santamarı́a, et al.. (2023). Neuroprotective and antioxidant effects of docosahexaenoic acid (DHA) in an experimental model of multiple sclerosis. The Journal of Nutritional Biochemistry. 124. 109497–109497. 10 indexed citations
8.
9.
Escribano, Begoña M., et al.. (2022). Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action. Inflammopharmacology. 30(5). 1569–1596. 61 indexed citations
10.
Escribano, Begoña M., Evelio Luque, Javier Caballero‐Villarraso, et al.. (2022). Sodium chloride-induced changes in oxidative stress, inflammation, and dysbiosis in experimental multiple sclerosis. Nutritional Neuroscience. 27(1). 74–86. 7 indexed citations
11.
Escribano, Begoña M., et al.. (2022). SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19. Journal of Neurology. 269(9). 4581–4603. 6 indexed citations
12.
Escribano, Begoña M., Evelio Luque, Paula Buendía, et al.. (2021). Lactose and Casein Cause Changes on Biomarkers of Oxidative Damage and Dysbiosis in an Experimental Model of Multiple Sclerosis. CNS & Neurological Disorders - Drug Targets. 21(8). 680–692. 7 indexed citations
13.
Luque, Evelio, Ignacio Ruz‐Caracuel, Eduardo Agüera, et al.. (2021). Transcranial Magnetic Stimulation Improves Muscle Involvement in Experimental Autoimmune Encephalomyelitis. International Journal of Molecular Sciences. 22(16). 8589–8589. 4 indexed citations
14.
Agüera, Eduardo, et al.. (2021). HIV infection and multiple sclerosis: a case with unexpected “no evidence of disease activity” status. Journal of International Medical Research. 49(3). 1221799129–1221799129. 6 indexed citations
15.
Fernández, Óscar, Guillermo Izquierdo, Eduardo Agüera, et al.. (2020). Comparison of first-line and second-line use of fingolimod in relapsing MS: The open-label EARLIMS study. Multiple Sclerosis Journal - Experimental Translational and Clinical. 6(3). 2455377326–2455377326. 7 indexed citations
16.
Escribano, Begoña M., Evelio Luque, Macarena Aguilar-Luque, et al.. (2018). The protective effect of extra-virgin olive oil in the experimental model of multiple sclerosis in the rat. Nutritional Neuroscience. 23(1). 37–48. 34 indexed citations
17.
Escribano, Begoña M., Macarena Aguilar-Luque, Fernando Sánchez‐López, et al.. (2016). Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing- Remitting Multiple Sclerosis. Current Pharmaceutical Design. 22(31). 4876–4880. 13 indexed citations
18.
Fernández, Francisco, Evelio Luque, Macarena Aguilar-Luque, et al.. (2016). Transcranial magnetic stimulation modifies astrocytosis, cell density and lipopolysaccharide levels in experimental autoimmune encephalomyelitis. Life Sciences. 169. 20–26. 33 indexed citations
19.
Blanco, Alfonso, Rosario Moyano, J. Vivo, et al.. (2006). Quantitative changes in the testicular structure in mice exposed to low doses of cadmium. Environmental Toxicology and Pharmacology. 23(1). 96–101. 66 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dake Huang Breakdown of academic impact, for papers by Gang Zhu Breakdown of academic impact, for papers by Xun Zhou Breakdown of academic impact, for papers by Fang Kuang Breakdown of academic impact, for papers by Jin Young Chung Breakdown of academic impact, for papers by Ágnes Zvara Breakdown of academic impact, for papers by T. Michael De Silva Breakdown of academic impact, for papers by Giacomo Pozzoli Breakdown of academic impact, for papers by Dayun Feng
Rankless by CCL
2026